Design Therapeutics, Inc. (DSGN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $537.43M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-771.00K; Retained Earnings (Accumulated Deficit)USD $-334.81M.
- 2026-03-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $532.96M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-268.00K; Retained Earnings (Accumulated Deficit)USD $-314.64M.
- 2025-12-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $509.10M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $403.00K; Retained Earnings (Accumulated Deficit)USD $-297.01M.
- 2025-09-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in Capital, Common StockUSD $480.37M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $358.00K; Retained Earnings (Accumulated Deficit)USD $-281.01M.
Design Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00K | $537.43M | $-771.00K | $-334.81M | $201.86M | 3 month · $3.87M 6 month · $7.79M |
| 2026-03-31 | $6.00K | $532.96M | $-268.00K | $-314.64M | $218.05M | 3 month · $3.92M |
| 2025-12-31 | $6.00K | $509.10M | $403.00K | $-297.01M | $212.50M | 12 month · $14.55M |
| 2025-09-30 | $6.00K | $480.37M | $358.00K | $-281.01M | $199.72M | 3 month · $3.59M 9 month · $11.11M |
| 2025-06-30 | $6.00K | $476.74M | $305.00K | $-264.01M | $213.04M | 3 month · $3.98M 6 month · $7.52M |
| 2025-03-31 | $6.00K | $472.39M | $450.00K | $-244.93M | $227.92M | 3 month · $3.54M |
| 2024-12-31 | $6.00K | $468.83M | $475.00K | $-227.21M | $242.10M | 12 month · $13.07M |
| 2024-09-30 | $6.00K | $465.10M | $914.00K | $-213.56M | $252.45M | 3 month · $3.12M 9 month · $9.60M |
| 2024-06-30 | $6.00K | $461.98M | $-217.00K | $-200.52M | $261.24M | 3 month · $3.30M 6 month · $6.48M |
| 2024-03-31 | $6.00K | $458.45M | $-167.00K | $-188.73M | $269.56M | 3 month · $3.18M |
| 2023-12-31 | $6.00K | $455.25M | $62.00K | $-177.63M | $277.69M | 12 month · $13.09M |
| 2023-09-30 | $6.00K | $452.02M | $-1.28M | $-165.78M | $284.96M | 3 month · $3.22M 9 month · $10.36M |
| 2023-06-30 | $6.00K | $448.78M | $-2.00M | $-150.00M | $296.80M | 3 month · $3.72M 6 month · $7.14M |
| 2023-03-31 | $6.00K | $444.85M | $-1.98M | $-130.06M | $312.82M | 3 month · $3.43M |
| 2022-12-31 | $6.00K | $441.42M | $-3.36M | $-110.76M | $327.31M | 12 month · $10.93M |
| 2022-09-30 | $6.00K | $438.22M | $-3.86M | $-93.42M | $340.94M | 3 month · $2.87M 9 month · $7.85M |
| 2022-06-30 | $6.00K | $435.19M | $-2.31M | $-75.72M | $357.16M | 3 month · $2.62M 6 month · $4.98M |
| 2022-03-31 | $6.00K | $432.35M | $-1.32M | $-60.72M | $370.31M | 3 month · $2.36M |
| 2021-12-31 | $6.00K | $429.82M | $-244.00K | $-47.46M | $382.13M | 12 month · $4.69M |
| 2021-09-30 | $6.00K | $427.95M | $-4.00K | $-36.39M | $391.56M | 3 month · $1.24M 9 month · $3.13M |
| 2021-06-30 | $6.00K | $426.68M | $-12.00K | $-25.07M | $401.60M | 3 month · $1.24M 6 month · $1.89M |
| 2021-03-31 | $6.00K | $425.44M | $2.00K | $-17.44M | $408.01M | 3 month · $647.00K |
| 2020-12-31 | $1.00K | $451.00K | $156.00K | $-11.92M | $-11.31M | 12 month · $450.00K |
| 2020-09-30 | (m) | (m) | (m) | (m) | $-7.89M | 3 month · $15.00K 9 month · $29.00K |
| 2020-06-30 | (m) | (m) | (m) | (m) | $-5.54M | 3 month · $10.00K 6 month · $14.00K |
| 2020-03-31 | (m) | (m) | (m) | (m) | $-4.12M | 3 month · $4.00K |
| 2019-12-31 | (m) | (m) | (m) | (m) | $-3.64M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |